Triple-negative breast cancer (TNBC) is a particularly aggressive subtype of breast cancer characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, which accounts for approximately 15% of all breast cancer cases [1, 2]. This evidence concerns the gene ERBB2 and breast carcinoma.